论文部分内容阅读
陶氏日本分公司在日本开发其总公司的杀虫剂spinocad(音译),拟在近期获得登记。该公司准备将该药剂开发成世界性的大型杀虫剂。 该药剂系由微生物发酵产生。其杀虫谱广,与现有杀虫剂有着不同的杀虫机理。并对人畜十分安全,认为有望与该公司现有的著名杀虫剂毒死蜱媲美。 spinocad系从土壤放线菌Saccharopolyspora spinosa分离而得具有大环内酯结构的
Dow Japan Co., Ltd. developed its parent company spinocad in Japan and plans to register it in the near future. The company is preparing to develop the drug into a world-wide large-scale insecticide. The pharmacological agent is produced by microbial fermentation. Its broad insecticidal spectrum has a different insecticidal mechanism than existing insecticides. It is also safe for humans and animals and believes that it is expected to be comparable to the company’s existing insecticides. Spinocad is isolated from soil actinomycete Saccharopolyspora spinosa and possesses macrolide structure